Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Aebischer

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Biomolecules|October 27, 2015
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's DiseaseWojciech Bobela, Patrick Aebischer, Bernard Laurent Schneider
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2004
Lentiviral-mediated gene transfer to model triplet repeat disordersEtienne Régulier, Diana Zala, Patrick Aebischer, et al.
Journal of Neurochemistry|June 7, 2005
Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin productionAli Sajadi, Matthias Bauer, Beat Thöny, et al.
Cold Spring Harbor Perspectives in Medicine|April 5, 2012
Parkinson's disease: gene therapiesPhilippe G Coune, Bernard L Schneider, Patrick Aebischer
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2005
Inducing tolerance to a soluble foreign antigen by encapsulated cell transplantsWilliam E Blanco-Bose, Bernard L Schneider, Patrick Aebischer
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 25, 2010
Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS miceChris Towne, Veronica Setola, Bernard L Schneider, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2008
Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS miceChris Towne, Cédric Raoul, Bernard L Schneider, et al.
Neurobiology of Disease|June 23, 2004
Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic miceSandrine Guillot, Mimoun Azzouz, Nicole Déglon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2003
Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin deliveryBernard Laurent Schneider, Frank Schwenter, William François Pralong, et al.
Human Molecular Genetics|September 4, 2003
Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatumEtienne Régulier, Yvon Trottier, Valérie Perrin, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Biomolecules|October 27, 2015
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's DiseaseWojciech Bobela, Patrick Aebischer, Bernard Laurent Schneider
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2004
Lentiviral-mediated gene transfer to model triplet repeat disordersEtienne Régulier, Diana Zala, Patrick Aebischer, et al.
Journal of Neurochemistry|June 7, 2005
Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin productionAli Sajadi, Matthias Bauer, Beat Thöny, et al.
Cold Spring Harbor Perspectives in Medicine|April 5, 2012
Parkinson's disease: gene therapiesPhilippe G Coune, Bernard L Schneider, Patrick Aebischer
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2005
Inducing tolerance to a soluble foreign antigen by encapsulated cell transplantsWilliam E Blanco-Bose, Bernard L Schneider, Patrick Aebischer
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 25, 2010
Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS miceChris Towne, Veronica Setola, Bernard L Schneider, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2008
Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS miceChris Towne, Cédric Raoul, Bernard L Schneider, et al.
Neurobiology of Disease|June 23, 2004
Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic miceSandrine Guillot, Mimoun Azzouz, Nicole Déglon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2003
Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin deliveryBernard Laurent Schneider, Frank Schwenter, William François Pralong, et al.
Human Molecular Genetics|September 4, 2003
Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatumEtienne Régulier, Yvon Trottier, Valérie Perrin, et al.
Pageof 10